Tag: GLP-1 receptor agonists
-
Incretin-Based Diabetes Drugs May Protect Against Dementia
Groundbreaking Findings from a Large-Scale McGill Study In a landmark analysis drawing on real-world clinical data from more than 450,000 patients, researchers at McGill University report that two classes of incretin-based medications used to treat Type 2 diabetes are associated with a reduced risk of dementia. The study adds to a growing body of evidence…
-
Drugs Without Nausea: Scientists Target Brain to Separate Side Effects
Overview: Aiming to keep the appetite, not the nausea Nausea is a common hurdle for millions using modern weight-loss medications, from GLP-1 receptor agonists to newer formulations. As scientists race to expand the benefits of these drugs, a central question guides the research: can the brain’s pathways be fine-tuned so that the appetite-suppressing effects remain,…
-
Could Ozempic and Wegovy Cut Cancer Death Risk? Emerging Study Sparks Hope and Caution
New findings spark hope for GLP-1 drugs Recent research points to a surprising potential benefit of GLP-1 receptor agonists — the same class that includes weight‑loss medications Ozempic and Wegovy. A growing body of observational data suggests these drugs may be associated with improved cancer survival, particularly in colon cancer. While the results are intriguing,…
-
Mother’s Mounjaro weight-loss tale ends in gallbladder surgery but no regrets
Rising hopes and a difficult turn Emma McDonald, a 38-year-old British mother, turned to Mounjaro (tirzepatide) in mid-2024 after years of struggling to lose weight following pregnancy. Like many women, she battled polycystic ovary syndrome (PCOS) and significant weight gain that began after giving birth. Emma recalls feeling she had exhausted other options: “Mounjaro was…
-
British Mother’s Mounjaro Journey: A Glimmer of Weight Loss Amid Gallbladder Nightmares
Introduction: A Weight-Loss Tale Intersected by Serious Medical Complications Emma McDonald, a 38-year-old British mother, sought a path to sustainable weight loss after pregnancy-related weight gain. Turning to Mounjaro, a GLP-1 receptor agonist known for its appetite-suppressing effects, she hoped to regain control of her health and PCOS symptoms. What began as a life-changing weight-loss…
-
British Mother’s Mounjaro Fight: From Rapid Weight Loss to Gallbladder Surgery
Overview: A Weight-Loss Journey Takes a Serious Turn A British mother’s attempt to reclaim her health using the diabetes and weight-loss drug Mounjaro has been marked by dramatic results and a frightening medical complication. Emma McDonald, 38, credits the GLP-1 receptor agonist with helping her shed pounds she felt were out of reach after pregnancy,…